Tenovir

Tenovir 50 tablet: Each film coated tablet contains Atenolol BP 50 mg. 

Tenovir tablet is indicated for the treatment of hypertension, angina,  arrhythmias,  early  intervention  in  acute  myocardial infarction. 

Usual recommended dose in hypertension is 50-100 mg daily, in angina is 100 mg daily in 1 or 2 doses and arrhythmias is 50-100 mg daily or as directed by the physician. 

Atenolol is contraindicated in heart failure, second or third degree heart block and in intermittent claudication. 

Atenolol crosses the placenta. The safety of atenolol if given in early pregnancy has not been established and its use should therefore be avoided.
Atenolol is excreted in breast milk. Breast feeding can be undertaken but infants should be monitored for bradycardia, respiratory depression, hypotension and hypoglycaemia.

Bradycardia,  heart  failure,  peripheral  vasoconstriction  and gastrointestinal disturbances may occur. 

Reduce oral dose of atenolol in liver disease, reduce initial dose of atenolol in renal impairment, patients who have a tendency towards obstructive airways disease should be treated with caution.
Abrupt withdrawal of atenolol should be avoided in angina.

Reserpine  may  have  an  additive  effect  when  given  with beta-blocking agents. So be closely observed for evidence of hypotension.  Calcium  channel  blockers  may  also  have  an additive effect when given with atenolol. 

Do not store above 25° C. 

Tenovir 50 tablet: Each box contains 100 tablets in blister pack.